van Deventer, Hendrik W <br/><br/>
Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia.  [electronic resource] 

 -  American journal of hematology  Nov 2002 
 - 184-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0361-8609 
<br/><br/><label>Standard No.: </label>10.1002/ajh.10215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Benzamides<br/>Cell Count<br/>Cytogenetic Analysis<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myeloid, Accelerated Phase--drug therapy<br/>Megakaryocytes--pathology<br/>Piperazines--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Thrombocytopenia--chemically induced<br/>Time Factors